Development and Evaluation of Sustained Release Matrix Tablets of Tramadol Hydrochloride
|
|
- Nickolas Fletcher
- 5 years ago
- Views:
Transcription
1 3364 Int J Pharm Sci Nanotech Vol 9; Issue 4 July August 2016 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 9 Issue 4 July August 2016 Research Paper MS ID: IJPSN BASARKAR Development and Evaluation of Sustained Release Matrix Tablets of Tramadol Hydrochloride Ganesh Basarkar*, Vijay Suryawanshi, and Dinesh Hire SNJB s SSDJ College of Pharmacy, Chandwad, Nashik , Maharastra, India. Received April 11, 2016; accepted May 25, 2016 ABSTRACT The objective of the present study was to control the release of freely water soluble Tramadol hydrochloride over a prolonged period of time by embedding the drug into novel wax matrix system. The matrix granules were prepared by melt granulation technique. The need for the administration two to four times a day when larger dose are required can decrease patient compliance. Sustained release formulation that would maintain plasma levels for 24 hrs for once daily dosing of Tramadol hydrochloride was prepared. The compatibility of the drug and wax examined using Differential Scanning Calorimetry (DSC) and Fourier Transform Infrared Spectrophotometer (FTIR). The effect of wax concentration (5 to 35%) and channeling agents (Avicel PH-101 and Di-calcium phosphate) on the in vitro KEYWORDS: Rice Bran Wax; Melt granulation; Sustain Release; Lipid matrix; Tramadol. drug release at 24 hrs. was studied. Results of DSC confirmed drug-wax compatibility. Increasing the wax concentration resulted in a significant retardation of drug release. The drug release study revealed that the optimized formulation (F6) 30% novel wax sustained drug release for 24hrs. At the same wax concentration, drug release from tablets decreased with Di-calcium phosphate and increased with Avicel PH 101. Kinetic modeling of in vitro dissolution profiles revealed the drug release mechanism ranges from diffusion controlled or Fickian transport to anomalous type or non-fickian transport. A hydrophobic matrix system is thus useful technique for prolonging the drug release of freely water soluble drugs such as Tramadol hydrochloride. Introduction Tramadol, chemically (+/-) cis-2-(dimethylamino) methyl) -1-(3-methoxy phenyl) cyclohexane hydrochloride, is a synthetic opioid of the aminocyclohexanol derivative. It is a centrally acting non-steroidal antiinflammatory drug (NSAID) with weak opioid agonist properties. It has been used since 1977 for the relief of strong physical pain and has been the most widely sold opioid analgesic drug in the world. It also proved to be effective in both experimental and clinical pain without causing serious cardiovascular or respiratory side effects (Jackson and Marrow, 2011). Tramadol inhibits reuptake of norepinephrine, serotonin and enhances serotonin release. It alters perception and response to pain by binding to mu-opiate receptors in the CNS. After oral administration, Tramadol is rapidly and completely absorbed (Jackson and Marrow, 2011). The half-life of Tramadol is about 5.5 hours and the usual oral dosage regimen is 50 to 100 mg every 4 to 6 hours with a maximum dosage of 400 mg/day. However, its mean absolute bioavailability is only 65-70% due to the first-pass hepatic metabolism. The extent of bioavailability increases to 77% after the rectal administration of Tramadol suppositories and to 100% after an intramuscular administration, in hours after the oral administration of drops, in 1-3 hour after the oral administration of tablet or capsule, and in 2-6 hour after the rectal administration of suppositories. Long term treatment with sustained release once daily is generally safe in patients with osteoarthritis or refractory low back pain and is well tolerated. The drug is freely soluble in water and hence judicious selection of release retarding excipients is necessary to achieve a constant in vivo input rate of drug (Reynolds, 1993). The matrix system is commonly used for manufacturing sustained-release dosage forms as it makes such manufacturing easy (Cardinal, 1984). The Non-bioerodible polymer and wax are commonly used as matrix forming components. The use of wax seems to have particular advantage due to wax s chemical inertness against other materials, good stability varying at ph and moisture levels, well established safe application in humans their non swellable and water insoluble nature. Preparation of matrix system has been discussed elsewhere (Bianhini and Vecchio, 1989; Cardinal, 1984; El-Egakey et al., 1971, Follonier and Doellcer, 1994; McTaggart et al., 1984). Hence, many ABBREVIATIONS: DSC: Differential Scanning Calorimetry; FTIR: Fourier Transform Infrared Spectrophotometer; NSAID: Non-Steroidal Anti-Inflammatory Drug; TB: Tapped Density; BD: Bulk Density. 3364
2 Basarkar: Development and Evaluation of Sustained Release Matrix Tablets of Tramadol Hydrochloride 3365 reports are published as techniques such as melt granulation, melt extrusion, pastillation, melt dispersion, and melt solidification. Design and application of these techniques depend on the physicochemical properties of the drug and excipients, as well as desired properties of the final product. Waxes like Bees wax, carnauba wax, cersine, micro crystalline wax, Percirol AT05, Gelucire 64/02, glyceryl monosterate, hydrogenated castor oil are used to prepare matrix granules and tablets. The aim of this study was to prepare sustain release lipid matrix tablets of Tramadol hydrochloride using Rice bran wax as insoluble lipid matrix. In the present study, a novel wax (Rice bran wax) was used to prepare matrix granules by melt granulation method. Rice bran wax is an important by product of Rice bran oil industry and belongs to (Oryza sativa) Family Graminae and is abundantly available (Sabale et al., 2003). The wax is reported to be chiefly Melissyl cerotate. Research at Southern Regional Research Laboratory has shown that the properties of refined and bleached wax are similar to that of the presently imported carnauba wax. Rice bran wax is better as a drug retardant or sustained release, confectionery and chewing gum than paraffin s or petrochemical waxes (Obaidat and Obaidat, 2000). Materials and Methods Tramadol hydrochloride was gifted from Sun pharma Limited & Neon pharma Limited, Rice bran wax was procured from Bajaj Rice mills Warangal (AP), lactose anhydrous was obtained from Zydus Cadilla, (Ahmedabad) Microcrystalline cellulose, Magnesium state, Di-calcium phosphate and talc were of analytical grade (Loba Chemie Pvt. Limited. Mumbai.) Purification and standardization of Rice Bran Wax The crude wax (100 g) was soxhleted with ethyl acetate (300 ml) for 30 min at 85 o C. The mixture in thimble was cooled up to 25 o C and was subjected to decolourization with 2% H 2 O 2 at 90 ºC for 1h and secondary decolourization with NaOCl 15% at 100 ºC for 1 h. The purified wax obtained was then used for further study. Drug-Excipients Compatibility Study The drug-excipients interaction study was carried out by using Differential scanning calorimetry (DSC) and FTIR spectrophotometer. FTIR Spectrophotometer The IR spectrum of Tramadol hydrochloride, Rice bran wax and combination of drug with Rice bran wax were recorded on KBR pellet with FTIR spectrophotometer. The IR absorption band in cm -1 of the drug and Rice bran wax used in the study were similar (Fig 1, 2, 3 and 4). Fig. 1. IR spectra for the drug Tramadol Hydrochloride. Fig. 2. Infrared spectrum of Rice bran wax. Fig. 3. IR spectrum of mixture of Tramadol hydrochloride and Rice bran wax (2:0.5). Fig. 4. IR spectrum of mixture of Tramadol hydrochloride and Rice bran.
3 3366 Int J Pharm Sci Nanotech Vol 9; Issue 4 July August 2016 Differential Scanning Calorimetry Thermal behavior of drug, wax and combinations with different ratios were studied by differential scanning calorimetry (DSC) using DSC-50, Shimadzu, Kyoto, Japan). The instruments were calibrated using indium standards. Accurately weighed samples (5-10 mg) were hermetically sealed in flat bottom aluminium standard 40 μl pans and heated from 50 to 300 o C at a rate of 10 o C/min. Melting endotherms of drug, wax and drug-wax combination were determined in the same way. Thermograms were normalized and rescaled as needed before overlapping. An empty Aluminium pan was used as reference (Fig. 5, 6, 7 and 8). Fig. 8. DSC thermogram of Tramadol and Rice bran wax (2:0.5). Preparation of Matrix Granules and Tablets Fig. 5. DSC thermogram of Tramadol wax. Fig. 6. DSC thermogram of Rice bran Hydrochloride. Sustained release granules were prepared using wax as a retarding material. For the preparation of sustained release formulation, purified Rice bran wax was used in different concentrations by trial and error basis. Rice bran wax granules were prepared by melting waxes by heating at constant temperature of 85 C. Drug and diluents were gradually added to the molten mass with continuous stirring (Miyagawa et al., 1996). Lactose anhydrous was used as diluents and channeling agent within the matrix of prepared tablets (Rezowanur et al., 2010). The molten mixture was then allowed to cool and solidify at room temperature and pulverized in mortar and sized through a 16 mesh sieve (Obaidat and Obaidat 2001) Prior to compression 0.5% (w/w), magnesium stearate was mixed with each batch of granules in poly bag for 5 min. A rotary tabletting machine (Karnavati Engg. Ltd. Rimek Minipress 2D), equipped with 10-mm flat faced circular punches was used to prepare tablets at a constant compression force. The composition with respect to wax concentration was selected on the basis of trial preparation of tablets. The composition of various prototype formulations with their codes is listed in Table 1. TABLE 1 Compositions of sustained release matrix tablets of Tramadol hydrochloride Formulations (Prototype formulations) (F1 - F7). Ingredients (mg) Tramadol hydrochloride Rice Bran Wax Lactose Anhydrous Magnesium Stearate Talc F1 F2 F3 F4 F5 F6 F (5%) 30 (10%) 45 (15%) 60 (20%) 75 (25%) 90 (30%) 105 (35%) (0.5%) 1.5 (0.5%) Total Fig. 7. DSC thermogram of Tramadol hydrochloride and Rice bran wax (2:2).
4 Basarkar: Development and Evaluation of Sustained Release Matrix Tablets of Tramadol Hydrochloride 3367 Physical Characterization of the Granules The packing properties were determined by measuring the difference between bulk density (BD) and the tapped density (TB) using standard procedures. In the procedure, a 30g quantity of granule sample was placed into 250 ml clean, dry measuring cylinder and the volume, V 0 occupied by the sample without tapping was determined. After 100 taps using Tap density tester (Electrolab Model ETD-1020), occupied volume, V 100 was also determined. The bulk and tap densities were calculated from these volumes (V 0 and V 100 ) using the formula: Density = Weight of sample/volume occupied by sample. From the data compressibility index (CI) values of the granules were calculated as CI = {(TB-BD)/ (TB} 100%. The flowability of the granules was determined by measuring the angle of repose formed when a sample of the granules (10 g) was allowed to fall freely from the stem of a funnel to a horizontal surface (Richards, 1972). Characterization of Tablets Uniformity of weight, fribiality was carried out as per IP, Hardness was measured using a simple Monsanto hardness tester (Tiwari et al., 2003; IP, 2007). Thickness was measured by using vernier caliper scale. Drug Content Twenty tablets were weighed individually and powdered in pestle mortar, and an amount equivalent to 100 mg of Tramadol hydrochloride was extracted with 100 ml of phosphate buffer (ph 6.8) and sonicated for 10 min. The solution was filtered through Whatman filter, and the content of Tramadol hydrochloride in the solution was determined by measuring absorbance on double beam UV spectrophotometer at 271 nm after suitable dilution (Tiwari et al., 2003). Dissolution Study For any formulation drug release from the dosage form is the foremost parameter to be measured. Drug release is evaluated by the in-vitro dissolution test apparatus. The In vitro dissolution studies were conducted using USP type II apparatus (TDT-08 L, Electrolab, Mumbai, India). The dissolution media is comprised of 0.1 N hydrochloric acid for the first 2 h and the phosphate buffer (ph 6.8) until 24 h (900 ml) kept at 37.0 ± 0.5 C and 50 rpm. An aliquot of 5 ml sample was withdrawn and replaced with another 5 ml of fresh dissolution medium at various time intervals. The contents of Tramadol hydrochloride in sample were determined by measuring absorbance at 271 nm in a UV- Visible spectrophotometer (JascoV-630). The absorbance values were transformed to concentration by reference to a standard calibration curve obtained experimentally. The release study was performed in triplicate (Tiwari et al., 2003). Effect of Channelling Agents The effect of different channelling agents like Avicel PH101 and di-calcium phosphate on in-vitro drug release was studied (Scott and Perry, 2003) and their composition is shown in Table 2. TABLE 2 Compositions of sustained release matrix tablets of Tramadol hydrochloride with different concentrations of channeling agents (F8 & F10). Ingredients (mg) F6 (Optimized) F8 F9 Tramadol hydrochloride DCP Lactose anhydrous Avicel PH Rice Bran Wax (%) 90 (30%) 90 (30%) 90 (30%) Magnesium stearate 1.5 (0.5%) 1.5 (0.5%) 1.5 (0.5%) Talc 1.5 (0.5%) 1.5 (0.5%) 1.5 (0.5%) Total Stability Studies The stability studies were carried out on the optimized formulation (F6), at 40 o C/ 75% RH for a period of three months as per ICH guidelines. The sample tablets were wrapped in the laminated aluminum foils and were placed in the accelerated stability chamber at 40 0 C/75% RH. Sampling was done at a predetermined time intervals of 30, 60 and 90 days. The tablets were evaluated for different physico-chemical parameters. Results and Discussion Drug-Excipient Compatibility Study Fig. 7 and 8 shows the thermogram of Tramadol hydrochloride and its physical mixtures (2:0.5 & 2:2 ratio, w/w) with the wax used. The DSC thermogram of the drug alone had main prominent sharp endothermic peak at 183 ºC which was reported to be corresponding melting point of Tramadol hydrochloride molecule. The thermograms of physical mixtures of the drug with wax used shown drug endothermic peak together with characteristic peak of the wax used, indicating that there was no interaction between the drug and wax used. Fig. 3 and 4 shows the IR spectra of Tramadol hydrochloride and its physical mixture (2:0.5 & 2:2 ratio, w/w) with the wax used. IR spectra of Tramadol hydrochloride show a broad peak at 3355 cm -1 may be due to hydrogen bonding, 3020 cm -1 may be due to aromatic C-H stretching of -OCH 3, the 2858 cm -1 may be due to C-H stretching of CH 2 group, 1585 & 1604 cm -1 may be due to C=C ring stretching, 1288, 1365 cm -1 CH bending of symmetric and asymmetric of CH 2 and CH 3 groups cm 1 may be due to C-0-C group and symmetric and asymmetric alkyl groups. 3529, 3610 & 3683 cm 1 may be due to free and bonded hydroxyl group of acidic compound present, 1604 to 1890 cm -1 may be due to C=O functional group of acid, ketone and ester containing molecules. 756 cm 1 one of the broad peak of the substituted aromatic compound. 1461, 1423 contain C=C group (Fig. 1). In addition to this IR spectrum of the drug: wax (2:0.5 & 2:2) shows characteristic absorption bands with negligible difference of absorption band values. Since there is no change in physical mixtures, it can be concluded that the drug maintains its identity
5 3368 Int J Pharm Sci Nanotech Vol 9; Issue 4 July August 2016 without going any chemical interaction with the wax used. Physicochemical Characterization of Rice Bran Wax The results of physicochemical properties of Rice bran wax are shown in Table 3. The wax was insoluble in maximum solvents except chloroform. The Acid value, Iodine value, Saponification value, peroxide value and all were within official limits. DSC Thermogram of rice bran wax is shown in Fig. 6. TABLE 3 Physicochemical properties of Rice bran wax. Test Unorganized wax Organized wax Solubility Chloroform Chloroform Melting range o C o C Acid value 25.94ml/gm 9.44ml/gm Peroxide value 63.8 meq/kg meq/kg Saponification value Iodine value 12 7 Evaluation of Granules: (Prototype Formulation) The granules were evaluated for BD, TBD, and angle of repose, Car s compressibility index and Hausner s ratio and shown in in Table 4. The angle of repose of matrices of all the formulation was found in the range of º to 27.04º indicating good properties. The BD and TBD for all the formulations were found in the range of to gm/cm 3 and to gm/cm 3 respectively. This result may further influence properties such as compressibility and tablet dissolution. The percentage of Car s compressibility index for all formulation lies within the range of to 16.8% and Hausner s ratio was found to be in the range of 1.13 to 1.23 showed good compressibility and good flow properties. Evaluation of Tablets Uniformity of weight: Uniformity of weight complies as per Indian Pharmacopoeia 2007 and shown in Table 5. This indicates that the drug content uniformity of all tablets was found to be satisfactory. Hardness and friability: The hardness values of the tablets ranged from 3.0 ± 0.52 to 4.2 ± 0.24 kg/cm 2 shown in Table 5. As the concentration of wax is increased, hardness of tablet also increased. However hardness alone cannot be considered as absolute indicator of the tablet strength. Hence, another parameter measured was the friability of the tablets. The friability of the tablets was found to be less than 1.0% and complies with IP. The measure of these two parameters gives the strength of the tablets during handling, packaging, shipping etc. Content of active ingredients: The drug content was found to be above 98.00% in all formulations and shown in Table 5. In Vitro Drug Release Profiles In-vitro drug release depends on several factors, such as the manufacturing process, the type of excipients and the amount of drug. In this work the effect of some diluents on Tramadol hydrochloride release was also studied. The result of dissolution studies on prototype formulations (F1 to F7) of Rice bran wax shown in Fig.9. Tablets F1, F2 and F3 released 41.59%, 28.58% and 24.06% of Tramadol hydrochloride at the end of 2 hrs and 96.80%, 81.37% and 67.51% respectively at the end of 8 hrs. F4, F5, F6 and F7 composed of Rice bran wax (20 to 35%) the released profile of formulations shows 21.36%, 19.79%, 17.39% and 15.92% of Tramadol hydrochloride at the end of 2 hrs and 95.60%, 85.80%, 73.12% and 67.55% at the end of 18 hrs respectively, shown in Table 6(a) and 6(b). TABLE 4 Evaluation data for matrix granules for formulations (Prototype formulations) F1-F7. Parameters Formulation Angle of Repose (θ) Bulk Density gm/cm 3 Tapped Density gm/cm 3 Hausner s Ratio (HR) Car s Index (%) F ± ± ± ± ± 1.9 F ± ± ± ± ± 1.0 F ± ± ± ± ± 1.76 F ± ± ± ± ± 0.74 F ± ± ± ± ± 1.3 F ± ± ± ± ± 1.89 F ± ± ± ± ± 0.32 TABLE 5 Evaluation data for matrix tablets for formulations ( Prototype formulations) F1-F7. Formulation Uniformity of Weight (mg) Thickness (mm) Hardness (kg/cm 2 ) Friability (%) Drug content (%) F ± ± ± F ± ± ± F ± ± ± F ± ± ± F ± ± ± F ± ± ± F ± ± ± All values are expressed as mean± SD, n=3
6 Basarkar: Development and Evaluation of Sustained Release Matrix Tablets of Tramadol Hydrochloride 3369 Time Formulations(% Cumulative drug release) (hr) F5 F6 F ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± 0.58 All values are expressed is mean ± SD, n=3 Drug Release Kinetics Fig. 9. The dissolution profile of matrix tablets (F1-F7) of Tramadol hydrochloride containing Rice bran wax. The wax ratio (F1 to F7) on release profile of Tramadol hydrochloride was studied and the decrease in drug release was observed when Rice bran wax content in the matrix was increased which is shown in Fig 9. It may be due to increased lipophilicity of waxy substance. In formulations F1 to F3 containing different concentrations of Rice bran wax the release of Tramadol hydrochloride get less retarded than those formulations of F4 to F7 it may be due to higher lipophilicity of wax. From the release study it is observed that, the F6 formulation shows 98.00% drug release in 24 hrs. This was the main aim of the present study. TABLE 6(a) The in-vitro dissolution data of matrix tablets for formulations F1- F4 containing different amounts of Rice bran wax (Prototype formulations). Time Formulations(% Cumulative drug release) (hr) F1 F2 F3 F ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± 0.71 All values are expressed is mean ± SD, n=3 TABLE 6(b) In vitro dissolution data of matrix tablets for formulations F5-F7 containing different amounts of Rice bran wax (Prototype formulations). Time Formulations(% Cumulative drug release) (hr) F5 F6 F ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± 0.14 The release kinetics of the matrices is shown in Table 7. The best fit model representing the mechanism of drug release from the matrices was of zero order. This is further confirmed by Higuchi, the value of n is less than 1 showing anomalous drug release, indicating that the drug release mechanism are diffusion coupling with slowly erosion. TABLE 7 The dissolution models for matrix tablets (F1-F7) of Tramadol hydrochloride. Formulation code R 2 Zero order N First order Higuchi Korsmeyer Peppas Korsmeyer Peppas F F F F F F F Effect of Channelling Agents The effect of channelling agents on in-vitro drug release study of matrix tablet was studied (Rezowanur et al., 2010). In this case, Avicel PH101 (F8) showed higher drug release than Lactose anhydrous (F6) and Dicalcium phosphate (F9) and shown in Table 8 and Fig. 10. This may be due to better network of channelling throughout the system to diffuse out the active into the dissolution medium by Avicel PH101. TABLE 8 Effect of channeling agents on in-vitro dissolution of Tramadol hydrochloride matrix tablets. Time (Hr) Formulations(% Cumulative drug release) F6 ( Lactose anhydrous) F8 (AvicelPH101)) F9 (DCP) ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± 0.52 All values are expressed is mean ± SD, n = 3
7 3370 Int J Pharm Sci Nanotech Vol 9; Issue 4 July August 2016 Fig. 10. Drug release profile different channeling agents from 5% to 35%. TABLE 9 Stability Data of Optimized Formulation. Stability (40 0 C ± 2 o C, 75 ±5% RH) Drug Release (%) after 24 hrs Assay (%) Initial Month Month Month Stability Studies The stability studies of optimum formulation revealed that no significant changes in the physicochemical parameters when stored at temperature and humidity conditions of 40 o C/ 75% RH and shown in Table 9. No significant reduction in the content of the active drug was observed over a period of three month. Conclusions Kinetic modeling of in vitro dissolution profiles revealed the drug release mechanism ranges from diffusion controlled or Fickian transport to anomalous type or non-fickian transport. A hydrophobic matrix system is thus useful technique for prolonging the drug release of freely water soluble drugs such as Tramadol hydrochloride. Acknowledgments Authors would like to thank Principal and management of SSDJ College of Pharmacy, Neminagar, Chandwad for providing all necessary facilities. Bianhini R and Vecchio C (1989). Oral controlled releaseoptimization of pellets prepared by extrusionspheronization processing. IL Farmaco 44: Cardinal J (1984). Matrix systems. In: Langer R., and Wise, D., (Eds.), Medical applications of controlled release, vol. 1, Classes of system, CRC Press, Boca Ralton, FL, El-Egakey M, Soliva M and Speiser P (1971). Hot extruded dosage forms, Part I, Technology and dissolution kinetics of polymeric matrices. Pharm Acta Helv 46: Follonier N and Doellcer E (1994). Evaluation of hot-melt extrusion as a new technique for the production of polymer-based pellets for sustained release capsule containing high loading of freely soluble drug. Drug Dev Ind Pharm 20: Ghali E, Klinger G and Schwartz J (1989). Thermal treatment of beads with wax for controlled release. Drug Dev Ind Pharm 15: IP (2007). Volume I, Government of India and Ministry of Health and Family welfare, Published by Indian Pharmacopoeia Commission, Ghaziabad, Jackson L and Marrow J (2011). Analgesic-Antipyretic & antiinflammatory agent and drug employed in the treatment of gout. In: Hardman JG, Limbird LE (Eds). Goodman and Gilman s The Pharmacological basis of Therapeutics. 10th edition. Mc-Graw Hill: McTaggart C, Ganley J, Sickmuller A and Walker S (1984). The evaluation of formulation and processing conditions of a melt granulation process. Int J Pharm 19: Miyagawa Y, Okabe T, Yamaguchi Y, Miyajima M, Sato H and Sunada H (1996). Controlled-release of diclofenac sodium from wax matrix granule. Int J Pharm 138: Namdeo T, Vidya R and Sushilkumar S (2010). Sustained-release from Layered Matrix System Comprising Rice Bran Wax and Sterculia Foetida Gum. International Journal of Pharm Tech Research 2: Obaidat A and Obaidat R (2000). Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate. Eur J Pharm Biopharm 52: Reynolds J (1993). Eds., In; Martindale; The Extra Pharmacopoeia, 29th Edn., The Royal Pharmaceutical Society of Great Britain, London, pp Rezowanur MR, Jahan ST, Sadat SMA and Jalil R (2010). Preparation and evaluation of mucoadhesive hydrophilic hydroxyl propyl methyl cellulose based extended release matrix tablets of niacin (nicotinic acid). American Journal of Scientific and Industrial Research 1(3): Richards J (1972). Powder flow and compaction In: Carter, S., (ed) Tutorial Pharmacy, Pitman Medical Publishing Ltd, London, 6 th, pp Roland A and Bodmeier C (2002). Waxes, Encyclopedia of Pharmaceutical Technology, 3: Sabale V, Sabale P and. Lakhotiya C (2003). Comparative Evaluation of Rice Bran Wax as an Ointment Base with Standard Base. Indian J Pharm Sci 71: Scott L and Perry C (2003). Tramadol: a review of its use in preoperative pain. Pain 60: Tiwari S, Krishna, M, Raveendra P, Mehta P and Chowdary P (2003). Controlled release formulation of tramadol hydrochloride using hydrophobic & hydrophilic matrix system. AAPS Pharm Sci Tech 4: References Banker G and Anderson N (1987). Tablets. In: Lachman L, Liberman HA, Kanig JL (Eds). The theory and practice of industrial pharmacy, 3rd edition, Varghese Publishing House, Bombay, pp Address correspondence to: Ganesh Basarkar, SNJB s SSDJ College of Pharmacy, Chandwad, Nashik , India. Ph: & basarkarg@yahoo.com & dinesh.hire11@gmail.com
Formulation Development and Evaluation of Sustained Release Matrix Tablets of Guaiphenesin
3312 Int J Pharm Sci Nanotech Vol 9; Issue 3 May June 2016 International Journal of Pharmaceutical Sciences and Nanotechnology Research Paper Volume 9 Issue 3 May June 2016 MS ID: IJPSN-4-6-16-BASARKAR
More informationFormulation and Development of Sustained Release Tablets of Valsartan Sodium
INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Research Article Formulation and Development of Sustained Release Tablets of Valsartan Sodium G. Sandeep * and A. Navya Department of
More informationVolume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL
Volume: 2: Issue-3: July-Sept -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL Ajaykumar Patil*, Ashish Pohane, Ramya Darbar, Sharanya Koutika, Alekhya
More informationPreparation and Evaluation of Silymarin Controlled Release Tablets Prepared Using Natural Gums
1368 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue 1 April-June 211 Research Paper International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue
More informationFormulation and evaluation of immediate release salbutamol sulphate
5 Formulation, optimization and evaluation of immediate release layer of salbutamol sulphate Salbutamol is moderately selective beta (2)-receptor agonist similar in structure to terbutaline and widely
More informationSTABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS
Int. J. Chem. Sci.: 8(1), 2010, 405-414 STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS V. L. NARASAIAH, T. KARTHIK KUMAR, D. SRINIVAS, K. SOWMYA, P. L. PRAVALLIKA and Sk. Md. MOBEEN
More informationEVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data
EVALUATION OF EFFERVESCENT FLOATING TABLETS 6.1 Technological characteristics of floating tablets 6.2 Fourier transform infrared spectroscopy (FT-IR) 6.3 Differential scanning calorimetry (DSC) 6.4 In
More informationCHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR
CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR Efavirenz and ritonavir, two widely prescribed anti retroviral
More informationMaisammaguda, Dulapally, Secundrabad.
121 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 3(6): November-December 2014 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY
More informationDESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN
Int. J. Chem. Sci.: 10(4), 2012, 2199-2208 ISSN 0972-768X www.sadgurupublications.com DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN K. V. R. N. S. RAMESH *, B. HEMA KIRNAMAYI
More informationFABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS
Int. J. Chem. Sci.: 7(4), 2009, 2555-2560 FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS HINDUSTAN ABDUL AHAD *, B. PRADEEP KUMAR, C.
More informationA Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac
Asian Journal of Chemistry Vol. 22, No. 6 (2010), 4239-4244 A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac K.P.R. CHOWDARY*
More informationResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Research Journal of Pharmaceutical, Biological and Chemical Sciences Formulation And Invitro Evaluation Of Sustained Release Matrix Tablets Of Ibuprofen S Shanmugam, T Vetrichelvan and P Niranjan* Adhiparasakthi
More informationFORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE COLON TARGETED TABLETS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE COLON TARGETED TABLETS G. Subba Rao
More informationFORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.1, No.4, pp 1381-1385, Oct-Dec 2009 FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS
More informationSTUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS
Int. J. Chem. Sci.: 10(4), 2012, 1934-1942 ISSN 0972-768X www.sadgurupublications.com STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS K. VENUGOPAL * and K. P. R. CHOWDARY a Nirmala College
More informationFormulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium
Available online on www.ijddt.com International Journal of Drug Delivery Technology 214; (3); 98-13 Research Article ISSN: 97 441 Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast
More informationFORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD
Int. J. Chem. Sci.: 6(3), 2008, 1270-1275 FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD K. P. R. CHOWDARY, P. TRIPURA SUNDARI and K. SURYA
More informationAsian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012
STUDIES ON EFFECT OF SUPERDISINTEGRANTS ON ETORICOXIB TABLET FORMULATIONS Chowdary K. P. R 1, Venugopal. K *2 1 College of Pharmaceutical Sciences, Andhra University, Vishakapattanam. 2 * Nirmala college
More informationJournal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp , Oct -Dec 2011
ISSN: 223-7346 Research Article Journal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp -394-43, Oct -Dec 211 FORMULATION AND INVITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF GLIMEPIRIDE
More informationVenkateswara Rao et.al Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)
Design and development of Metformin hydrochloride Tried sustained release tablets Venkateswara Rao T 1 *, Bhadramma N 1, Raghukiran CVS 2 and Madubabu K 3 Bapatla College of Pharmacy, Bapatla, Guntur-522101
More informationDevelopment and evaluation of controlled release mucoadhesive tablets of Tramadol Hydrochloride
Development and evaluation of controlled release mucoadhesive tablets of Tramadol Hydrochloride R. Margret Chandira*, C.M. Sahu and B. Jayakar Department of Pharmaceutics Vinayaka Mission s College of
More informationBahadur S. et al /J. Pharm. Sci. & Res. Vol.1(4), 2009,
Abstract: In the present work, we developed an effective mucoadhesive tablets of omeprazole(diomeprazole magnesium powder and omeprazole pellets) by direct punch method with excellent mucoadhesive force
More informationInternational Journal of Medicine and Pharmaceutical Research
International Journal of Medicine and Pharmaceutical Research Journal Home Page: www.pharmaresearchlibrary.com/ijmpr Research Article Open Access Formulation and Evaluation of Gastroretentive Floating
More informationAvailable Online through Research Article
ISSN: 0975-766X Available Online through Research Article www.ijptonline.com DESIGN AND EVALUATION OF GASTRORETENTIVE TABLETS FOR CONTROLLED DELIVERY OF NORFLOXOCIN Ganesh Kumar Gudas*, Subal Debnath,
More informationFormulation and evaluation of oro-dispersible tablets of lafutidine
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):226-235 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationFORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE
Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 975-1491 Vol 4, Suppl 5, 212 FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE
More informationPharmaceutical Studies on Formulation and Evaluation of Sustained Release Tablets Containing Certain Drugs
Mansoura University Faculty of Pharmacy Department of Pharmaceutics Pharmaceutical Studies on Formulation and Evaluation of Sustained Release Tablets Containing Certain Drugs Thesis presented by Ali Saeed
More informationFeasibility of using natural gums for development of sustained release matrix tablet of itopride
Available online at wwwscholarsresearchlibrarycom Scholars Research Library Der Pharmacia Lettre, 215, 7 (3):114-123 (http://scholarsresearchlibrarycom/archivehtml) ISSN 975-571 USA CODEN: DPLEB4 Feasibility
More informationFORMULATION RELEASE STUDY OF SOME IMPORTANT DRUGS FROM SUPPOSITORY
FORMULATION RELEASE STUDY OF SOME IMPORTANT DRUGS FROM SUPPOSITORY Mohammed Younus Ali*, Sadat Ali JJT University, Churu-Bisau Road, Jhunjhunu Rajasthan ABSTRACT: The purpose of this study was to formulate
More informationOPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105
Digest Journal of Nanomaterials and Biostructures Vol. 9, No. 3, July September 2014, p. 1077-1084 OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105
More informationAsian Journal of Research in Biological and Pharmaceutical Sciences
Research Article ISSN: 2349 4492 Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com APPLICATION OF FACTORIAL DESIGN AND OPTIMIZATION OF GLIMEPIRIDE SUSTAINED
More informationFORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES
Int. J. Chem. Sci.: 10(1), 2012, 297-305 ISSN 0972-768X www.sadgurupublications.com FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES K. P.
More informationFormulation and evaluation of sublingual tablets of lisinopril
Journal of GROVER Scientific & Industrial AGARWAL: Research FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF LISINOPRIL Vol. 71, June 2012, pp. 413-417 413 Formulation and evaluation of sublingual tablets
More informationDesign and In-vitro Evaluation of Silymarin Bilayer Tablets
CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original Article Design and In-vitro Evaluation of Silymarin
More informationFormulation development of Glipizide matrix tablet using different proportion of natural and semi synthetic polymers
Pharm Methods, 2017; 8(1): 45-53 A multifaceted peer reviewed journal in the field of Pharm Analysis and Pharmaceutics www.phmethods.net www.journalonweb.com/phm Research Article Formulation development
More informationInternational Journal of Chemistry and Pharmaceutical Sciences
Ramesh Naik M et al IJCPS, 2014, Vol.2(11): 1259-1264 Research Article ISSN: 2321-3132 International Journal of Chemistry and Pharmaceutical Sciences Fabrication and Evaluation of Montelukastsodium Sustained
More information3.1 Background. Preformulation Studies
Preformulation Studies 3.1 Background Delivery of any drug requires a suitable dosage form to get optimum therapeutic effects. The development of such dosage forms fundamental properties of the drug molecule
More informationDEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED RELEASE FLOATING MATRIX TABLETS OF METFORMIN HYDROCHLORIDE
ISSN: 0975-8232 IJPSR (2010), Vol. 1, Issue 8 (Research article) Received 11 April, 2010; received in revised form 17 June, 2010; accepted 13 July, 2010 DEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED
More informationJournal of Global Trends in Pharmaceutical Sciences. Journal home page:
ISSN: 2230-7346 G Sridhar Babu et al. / JGTPS/ 5(4)-(2014) 2085-2092 (Research Article) Journal of Global Trends in Pharmaceutical Sciences Journal home page: www.jgtps.com FORMULATION AND IN-VITRO CHARACTERIZATION
More informationFORMULATION AND EVALUATIONOF AMOXYCILLIN: THREE-LAYER GUAR GUM MATRIX TABLET
Gupta and Singh, IJPSR, 2013; Vol. 4(7): 2683-2690. ISSN: 0975-8232 IJPSR (2013), Vol. 4, Issue 7 (Research Article) Received on 05 March, 2013; received in revised form, 29 April, 2013; accepted, 29 June,
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(3):159-164 Studies on formulation and in vitro evaluation
More informationFormulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch
Abstract K.P.R. Chowdary et al. / International Journal of Pharma Sciences and Research (IJPSR) Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch K.P.R. Chowdary*,
More informationFORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS
International Journal of PharmTech Research CODEN( USA): IJPRIF ISSN : 0974-4304 Vol.1, No.3, pp 634-638, July-Sept 2009 FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS K. Reeta Vijaya
More informationDevelopment And Invitro Characterization Of Tramadol Hydrochloride Sustained Release Tablets
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.2, pp 492-500, April-June 2013 Development And Invitro Characterization Of Tramadol Hydrochloride Sustained Release
More informationFormulation and In vitro Release Characterization of Metoprolol Succinate Extended Release Tablets
Sakthikumar et al: Formulation and In vitro Release Characterization of Metoprolol Succinate Extended Release Tablets 1537 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article FORMULATION AND EVALUATION OF IMMEDIATE RELEASE VENLAFAXINE HCL TABLETS: COMPARATIVE STUDY OF SUPER DISINTEGRANT
More informationFORMULATIO A D EVALUATIO OF ORO DISPERSIBLE TABLETS OF CLO AZEPAM BY DIRECT COMPRESSIO METHOD
FORMULATIO A D EVALUATIO OF ORO DISPERSIBLE TABLETS OF CLO AZEPAM BY DIRECT COMPRESSIO METHOD THAKKAR HARDIK R*, A.SENTHIL, RAVIKUMAR, V.B. NARAYANA SWAMY Karavali College of Pharmacy, Mangalore-575028,
More informationFormulation and Evaluation
Chapter-5 Formulation and Evaluation 5.1 OBJECTIVE After successful taste masking and solubility enhancement of drugs in preliminary studies, by using Mannitol Solid Dispersion, next step includes the
More informationScholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011, 3(1): 38-44 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationEffect of Polymer Concentration and Viscosity Grade on Atenolol Release from Gastric Floating Drug Delivery Systems
Effect of Polymer Concentration and Viscosity Grade on Atenolol Release from Gastric Floating Drug Delivery Systems 1 1 1 2 U.V. Bhosale*, V. Kusum Devi, Nimisha Jain and P.V. Swamy 1 Al-Ameen College
More informationOptimization of Atenolol Core Tablet CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS
CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS 5.1. AIM OF THE STUDY The pulsatile type press coated colon targeted atenolol tablet release drug after 6 hr lag time. The compression coated
More informationDESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG M Seth *, DS Goswami,
More informationJournal of Pharmaceutical and Scientific Innovation
Journal of Pharmaceutical and Scientific Innovation www.jpsionline.com (ISSN : 2277 4572) Research Article ASSESSING THE BEST POLY VINYL PYRROLIDONE AS A CARRIER FOR ETORICOXIB SOLID DISPERSIONS: FABRICATION
More informationFormulation and Evaluation of Indomethacin Bilayer Sustained Release Tablets
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol. 3, No.2, pp 1132-1138, April-June 2011 Formulation and Evaluation of Indomethacin Bilayer Sustained Release Tablets
More informationDEVELOPMENT AND EVALUATION OF A DIRECTLY COMPRESSIBLE CO PROCESSED MULTIFUNCTION SUSTAINED RELEASE AGENT FOR TABLETS
International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 975-1491 Vol 2, Suppl 4, 1 Research Article DEVELOPMENT AND EVALUATION OF A DIRECTLY COMPRESSIBLE CO PROCESSED MULTIFUNCTION SUSTAINED
More informationVolume: I: Issue-3: Nov-Dec ISSN
Volume: I: Issue-3: Nov-Dec -2010 ISSN 0976-4550 DESIGN AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF GLIMEPIRIDE BASED ON COMBINATION OF NATURAL AND SYNTHETIC POLYMERS Hindustan Abdul Ahad 1,
More informationInternational Journal of Drug Research and Technology
Int. J. Drug Res. Tech. 2016, Vol. 6 (3), 141-149 ISSN 2277-1506 International Journal of Drug Research and Technology Available online at http://www.ijdrt.com Original Research Paper FORMULATION AND EVALUATION
More informationJournal of Advanced Scientific Research. Formulation and Evaluation of Glimepiride Solid Dispersion Tablets for Their Solubility Enhancement
Wagh V.T. et al, J Adv Sci Res, 2012, 3(4): 36-41 36 Journal of Advanced Scientific Research Available online through http://www.sciensage.info/jasr ISSN 0976-9595 Research Article Formulation and Evaluation
More informationPREPARATION AND INVITRO EVALUATION OF RABEPRAZOLE SODIUM DELAYED RELEASE ENTERIC COATED TABLETS
Page1000 Indo American Journal of Pharmaceutical Research, 2014 ISSN NO: 2231-6876 Journal home page: http:///index.php/en/ INDO AMERICAN JOURNAL OF PHARMACEUTICAL RESEARCH PREPARATION AND INVITRO EVALUATION
More informationMixed Hydrotropy: Novel Science of Solubility Enhancement
Research Paper Mixed Hydrotropy: Novel Science of Solubility Enhancement R. K. MAHESHWARI* AND Y. JAGWANI Shri G. S. Institute of Technology and Science, 23-Park Road, Indore-452 003, Madhya Pradesh, India
More informationSivakasi , Tamil Nadu, India. ABSTRACT KEYWORDS:
276 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 4(1): January-February 2015 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND
More informationComparative study of different solubility enhancement techniques on dissolution rate of zaltoprofen
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationAvailable online through ISSN
Research Article Available online through www.ijrap.net ISSN 2229-3566 FORMULATION AND EVALUATION OF ORO DISPERSIBLE TABLETS OF METOPROLOL TARTRATE BY DIRECT COMPRESSION USING SUPER DISINTEGRANTS A. Senthil*
More informationPreparation And Optimisation Of Valsartan Bilayered Sustained Release Matrix Tablets
ISSN 976 3333 Available Online at www.ijpba.info. International Journal of Pharmaceutical & Biological Archives 211; 2(3):914-92 ORIGINAL RESEARCH ARTICLE Preparation And Optimisation Of Valsartan Bilayered
More informationPatel B et al. IRJP 1 (1)
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY Available online http://www.irjponline.com Research Article IMPROVEMENT OF SOLUBILITY OF CINNARIZINE BY USING SOLID DISPERSION TECHNIQUE Patel Bipin*, Patel Jayvadan,
More informationA STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE FORMS
International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 1, Suppl 1, Nov.-Dec. 2009 Research Article A STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE
More informationInt. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:
International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2014; 4(1):47-51 Research Article FORMULATION AND EVALUATION
More informationPatel Krunal M et al. IRJP 2 (2)
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN 223 87 Available online http://www.irjponline.com Research Article DESIGN DEVELOPMENT AND EVALUATION OF MODIFIED RELEASE TABLET OF MONTELUKAST SODIUM BY
More informationFabrication and evaluation of Nimesulide Azadirachta indica fruit mucilage based sustained release matrix tablets
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.2, No.2, pp 937-941, April-June 2010 Fabrication and evaluation of Nimesulide Azadirachta indica fruit mucilage based
More informationJournal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2013, 5(1):320-328 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development of modified release tablet dosage forms
More informationAsian Journal of Research in Biological and Pharmaceutical Sciences Journal home page:
Research Article ISSN: 2349 4492 Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com DESIGN, DEVELOPMENT AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM
More informationThis PDF is available for free download from a site hosted by Medknow Publications
26 CMYK Research Paper Possible Use of Psyllium Husk as a Release Retardant ANGIRA DESAI, SUPRIYA SHIDHAYE*, V. J. KADAM Department of Pharmaceutics, Bharati Vidhyapeeth s College of Pharmacy, Sector-8,
More informationGlobal College of Pharmacy, Kahnpur Khui, Tehsil Anandpur Sahib, Distt.- Ropar, Punjab, India
IJPSR (2012), Vol. 3, Issue 09 (Research Article) Received on 19 May, 2012; received in revised form 25 June, 2012; accepted 27 August, 2012 IN-VITRO EVALUATION OF TWO MARKETED BRANDS OF PARACETAMOL TABLETS
More informationFormulation and evaluation of gastro retentive floating tablets of Terbutaline sulphate
Formulation and evaluation of gastro retentive floating tablets of Terbutaline sulphate Lokesh Kumar*, Virendra Singh, Rakesh Kumar Meel Department of Pharmaceutics, Goenka College of Pharmacy, NH-11,
More informationStudy of Disintegrant Property of Moringa Oleifera Gum and its Comparison with other Superdisintegrants
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol. 3, No.3, pp 1119-1124, July-Sept 2011 Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with
More informationInternational Journal of Institutional Pharmacy and Life Sciences 3(6): November-December 2013
International Journal of Institutional Pharmacy and Life Sciences 3(6): November-December 2013 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!!
More informationDesign and development of fast Melting Tablets of Terbutaline Sulphate
Design and development of fast Melting Tablets of Terbutaline Sulphate Mathew T and Agrawal S Swami Vivekanand College of Pharmacy, Khandwa Road, Indore (MP), INDIA Available online at: www.isca.in (Received
More informationFormulation Development and Evaluation of Modified Release Tablet using a Fixed Dose Combination of Antidiabetic Agents
Research Article Formulation Development and Evaluation of Modified Release Tablet using a Fixed Dose Combination of Antidiabetic Agents Nishit Gohel 1*, D M Patel 2, Komal Patel 3, Jignasa Modi 4 1 School
More informationVol-3, Issue-4, Suppl-1, Nov 2012 ISSN: Patel et al PHARMA SCIENCE MONITOR
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES FORMULATION AND IN-VITRO EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF DOMPERIDONE Rahul B. Patel *, K. R. Patel, M. R. Patel, N.
More informationFORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES
Volume: 2: Issue-4: Oct - Dec -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER 407 - PVPK30 INCLUSION COMPLEXES K.P.R. Chowdary*, K. Surya Prakasa
More informationFormulation and Evaluation of Metronidazole Enteric Coated Tablets for Colon Targeting
Human Journals Research Article May 2015 Vol.:3, Issue:2 All rights are reserved by Srilakshmi N et al. Formulation and Evaluation of Metronidazole Enteric Coated Tablets for Colon Targeting Keywords:
More informationFormulation Development and Evaluation of Atorvastatin Calcium Tablets using Co-Processed Excipients
Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 39, Pages: 217222 Research Article Formulation Development and Evaluation of Atorvastatin Calcium Tablets using CoProcessed Excipients
More informationInt. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:
International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2013; 3(6):42-46 Research Article ENHANCEMENT OF SOLUBILITY
More informationDEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE
IJPSR (2013), Vol. 4, Issue 5 (Research Article) Received on 17 July, 2012; received in revised form, 23 February, 2013; accepted, 14 April, 2013 DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL
More informationFormulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting
Formulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting Biresh Kumar Sarkar* 1, Devananda Jain 1, Mamta Parwal 2 1. Bhagwant University, Dept.of Pharmaceutical Tech and Sciences,
More informationAvailable online at Scholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011: 3 (4) 380-392 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationAdimoolam Senthil et al. IRJP 2 (1)
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN 2230 8407 Available online http://www.irjponline.com Research Article DEVELOPMENT AND EVALUATION OF ORALLY DISINTEGRATING TABLETS OF METOPROLOL TARTRATE
More informationDesign and Characterisation of Sustained Release Microcapsules of Salbutamol Sulphate
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.2, No.2, pp 1144-1149, April-June 2010 Design and Characterisation of Sustained Release Microcapsules of Salbutamol
More informationFormulation and evaluation of sustained release matrix tablet of metoprolol succinate
17; 3(5): 448-453 ISSN Print: 2394-7500 ISSN Online: 2394-5869 Impact Factor: 5.2 IJAR 17; 3(5): 445-453 www.allresearchjournal.com Received: 15-03-17 Accepted: -04-17 Mangesh R Bhalekar Ashwini R Madgulkar
More informationMuniyandy SARAVANAN,*,a Kalakonda SRI NATARAJ, a and Kettavarampalayam Swaminath GANESH b
978 Notes Chem. Pharm. Bull. 51(8) 978 983 (2003) Vol. 51, No. 8 Hydroxypropyl Methylcellulose Based Cephalexin Extended Release Tablets: Influence of Tablet Formulation, Hardness and Storage on in Vitro
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES
Research Article Formulation, Development and Evaluation of Fast Dissolving Tablet of Salbutamol Sulphate by Using Superdisintegrants of Various Concentrations Santosh K 1 *, Meenakshi B 2 and Jyoti M
More informationJournal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Studies on Carica Papaya Starch as a Pharmaceutical Excipient
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2012, 4(6):3134-3138 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Studies on Carica Papaya Starch as a Pharmaceutical
More informationDevelopment and Evaluation of Pulsatile Drug Delivery System Containing Etodolac
Human Journals Research Article December 2016 Vol.:8, Issue:1 All rights are reserved by Amit A. Dhengale et al. Development and Evaluation of Pulsatile Drug Delivery System Containing Etodolac Keywords:
More informationFormulation and In-Vitro Evaluation of Leflunomide Tablet with Enhanced Dissolution
ISSN 2395-3411 Available online at www.ijpacr.com 486 Research Article Formulation and In-Vitro Evaluation of Leflunomide Tablet with Enhanced Dissolution Ghanshayma M. Patil*, Harshal K. Patil, Vipul
More informationFORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF BILAYER TABLETS OF AMOXICILLIN AND FAMOTIDINE
ISSN: 2395 1338 FORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF BILAYER TABLETS OF AMOXICILLIN AND FAMOTIDINE B. Venkateswara Reddy *, K. Navaneetha Department of Pharmaceutics, St.Paul s College
More informationFORMULATION DEVELOPMENT AND EVALUATION OF COLON TARGETED DOSAGE FORM OF IBUPROFEN
FORMULATION DEVELOPMENT AND EVALUATION OF COLON TARGETED DOSAGE FORM OF IBUPROFEN Pranjal Kumar Singh*, Sanjoo Kumar, T.S.Easwari, V.K.Shukla, Guru Sharan Department of Pharmaceutics, IIMT College of Medical
More informationInt. J. Pharm. Sci. Rev. Res., 28(1), September October 2014; Article No. 21, Pages:
Research Article V.T. Iswariya 1 *, A Hariom Prakash Rao 1, V Lokeswara Babu 1, Mohd Abdul Hadi 1, A Srinivasa Rao 2 1 Dept. of Pharmaceutics, Bhaskar Pharmacy College, Bhaskar Nagar, Yenkapally (V), Moinabad
More information7. SUMMARY, CONCLUSION AND RECOMMENDATIONS
211 7. SUMMARY, CONCLUSION AND RECOMMENDATIONS Drug absorption from the gastro intestinal tract can be limited by various factors with the most common one being poor aqueous solubility and poor permeability
More informationFormulation and evaluation of Orodispersible tablets to enhance dissolution rate of Lamotrigine by using Solid Dispersion Technique
35 Formulation and evaluation of Orodispersible tablets to enhance dissolution rate of Lamotrigine by using Solid Dispersion Technique Bhumi B. Patel 1 *, Chainesh N. Shah 2, Rumit M. Shah 3 1 Department
More information